Cantor BioConnect Sold to Prairie Capital

Prairie Capital Recapitalizes Kashi Clinical Laboratories

June 20, 2024

Healthcare Services

Prairie Capital partnered with founder Dr. Zahra Kashi and senior management to recapitalize Kashi Clinical Laboratories, a Portland, Oregon-based accredited clinical laboratory specializing in HLA typing, post-transplant monitoring, genomic sequencing and diagnostic testing. Prairie will support accelerated growth through investments in human capital, sales & marketing, technology and infrastructure, as well as pursuing add-on acquisitions.

Ampersand Capital Partners Acquires Biologos LLC

March 19, 2024

Biotechnology

Ampersand Capital Partners, a healthcare-focused private equity firm, has acquired Biologos LLC, a Glendale Heights, Illinois-based manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. Ampersand will invest to expand Biologos' capabilities, product offerings, and geographic reach, and has appointed Frank Witney as Chairman with two Ampersand principals joining the board.

Avista Capital Partners Acquires Taconic Biosciences

November 1, 2022

Biotechnology

Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Taconic, a Rensselaer, New York–based provider of genetically engineered murine research models and related preclinical services, will leverage Avista's healthcare investing expertise to pursue organic growth and strategic acquisitions in the GEMs market.

Bruker Corporation Acquires Canopy Biosciences, LLC

September 11, 2020

Biotechnology

Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.

Prairie Capital VI Recapitalizes Netalytics

February 21, 2020

Cloud & SaaS

On February 21, 2020 Prairie Capital VI, LP partnered with founders Mark and Karen Essex to recapitalize Netalytics, a Greer, South Carolina provider of electronic medical records (EMR) and practice management solutions serving the substance use disorder (SUD) / opioid use disorder (OUD) market. Prairie Capital said it will support growth through investments in human capital, sales and marketing, technology and infrastructure, service-line expansion and add-on acquisitions.

Praesidian Capital Acquires Undisclosed Genetics Business

September 18, 2019

Healthcare Services

Praesidian Capital announced the acquisition of an integrated clinical and laboratory services company operating in genetic medicine, focused on prenatal and preconception testing and hereditary cancer risk assessments. The deal is Praesidian’s first as an independent sponsor and will serve as a platform for national expansion and future add-on acquisitions.